In a retrospective study, nearly half (11/21) of CD70-deficient and 36% (12/33) of CD27-deficient patients developed lymphomas, with Hodgkin’s lymphoma (HL) being the most common malignancy (Table 1) [50,51]. This evidence concerns the gene CD27 and lymphoma.